| Subject: |
|
Re: Re: Re: John Holcombe of Lilly--In His Own Words!! |
| Name: |
|
junkprincess |
| Date Posted: |
|
Feb 23, 06 - 11:10 AM |
| IP Address: |
|
68.165.42.115 |
| Message: |
|
"After Thoughtful Consideration", Lilly Has Decided NOT To Find A Cure For Diabetes"
Would You Cure A Profitable Disease? Dara Mayers October 2003
In 1997, Lilly licensed INGAP, a protein discovered by Dr. Aaron Vinik of Eastern Virginia Medical School, which was deemed to have potential as a cure for both type 1 and type 2. INGAP causes the regeneration of beta cells in the pancreas and has the potential to be a truly innovative treatment for diabetes.
Early clinical tests carried out by Lilly were quite successful. Vinik reports that animal studies showed a 30 to 40 percent reversal rate of diabetes.
In 1999, however, Lilly dropped INGAP from its portfolio. According to Vinik, it was not the science that the people at Lilly lost interest in.
“They said, ‘We love the science, but we don’t think that it is a good business model,’” he recalls.
INGAP was part of our portfolio, and during ongoing review of our priorities, it was decided we would drop it,” states Dr. John Holcombe, medical adviser for Lilly research laboratories. “It was a very tough decision. It wasn’t dropped because it wasn’t showing promise. A lot of the things we do show promise, but we just can’t do everything. We had to make a tough decision, and other things became more important than INGAP. You just don’t have unlimited resources.”
“Even with good control, people are not immune to complications,” Holcombe notes, adding that drugs to combat eye, kidney and nerve damage will play an important role in Lilly’s future.
Indiana Medical Licensing Board
Name: JOHN HUTCHINGS HOLCOMBE
License Type: Physician
You expected him to be a doctor, and with all of his insulin and diabetes "knowledge", a specialist:
Indiana University at Indianapolis August 8, 1989 Initial Appointments
25. John H. Holcombe as Clinical Associate Professor of Pediatrics, School of Medicine, for the period July 1, 1989 to June 30, 1992, without stipend.
PEDIATRICIAN, not ENDOCRINOLOGIST
A specialist in treating CHILDREN, not DIABETES. You can't talk to KIDS the way he's spoken to and about those with diabetes. Lilly's descriptions of him are of him as a specialist in diabetes, as per their material. Looking at his employment then, while he was insulting diabetics as a "diabetes specialist" for Eli Lilly, he was an Associate Professor of Pediatrics for Indiana University. Lilly's invention of the "diabetes specialist" title does NOT make him an Endocrinologist--not before any medical licensing board. His specialty is qualified to pass judgment on pablum--not insulin.
Another Lilly Lie--the kiddie doctor is a diabetes specialist. When employing medical consultants, they might be more credible if their qualifications matched the area they are employed in. There must have been willing and capable Endocrinologists available for the Lilly position, but perhaps they failed Lilly's test of simply nodding in agreement to all company propaganda, right or wrong.
Guess he wasn't "trying hard enough" to change his specialty, even with Lilly's title--just as he accused those unable to use human insulin of not doing.    
The tragedy is the cost of Lilly's Shell Game to those needing natural insulins.   |
|
|
|
|
|
|
Reply
Home
bravenet.com